Author Question: A patient who is taking colchicine for gout is in the clinic 1 week after beginning the medication. ... (Read 64 times)

kaid0807

  • Hero Member
  • *****
  • Posts: 515
A patient who is taking colchicine for gout is in the clinic 1 week after beginning the medication. The patient reports decreased appetite and nausea. The primary care NP should:
 
  a. suspect worsening of gouty arthritis.
  b. order vitamin B12 levels to assess for vitamin deficiency.
  c. discontinue the colchicine for 48 hours until symptoms subside.
  d. reassure the patient that these are common, temporary side effects.

Question 2

A 12-year-old patient who is obese develops type 2 diabetes mellitus. The primary care NP should order:
 
  a. nateglinide (Starlix).
  b. glyburide (Micronase).
  c. colesevelam (Welchol).
  d. metformin (Glucophage).



Animal_Goddess

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

C
Colchicine toxicity causes nausea, vomiting, and anorexia. When toxicity is suspected, the medication should be temporarily discontinued and restarted after symptoms subside.

Answer to Question 2

D
Metformin is the only drug listed that is recommended for children.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

kaid0807

  • Hero Member
  • *****
  • Posts: 515
Both answers were spot on, thank you once again




 

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

For a complete list of videos, visit our video library